13 documents found, page 1 of 2

Embracing a New Chapter at Birth and Growth Medical Journal, in times of new fo...

Hypokalemia and hyperkalemia: Two Sides of the Same Coin

Introduction: Potassium (K+) is the main intracellular cation and is crucial for normal cellular function, especially during children’s development and growth course. Changes in the homeostatic mechanisms of potassium regulation can lead to hypokalemia or hyperkalemia. Objective: This study aimed to provide a narrative review of this common, yet complex, condition of the clinical practice. Development/Conclusio...

Resistência à terapêutica com eritropoietina humana recombinante em doentes hem...

Com o objectivo de clarificar o mecanismo de resistência à terapêutica com eritropoietina humana recombinante (EPOhr) em doentes hemodializados, estudamos alterações a ela associada, com particular interesse na inflamação, activação leucocitária, ciclo do ferro, stress oxidativo e lesão eritrocitária. Foram estudados 63 doentes renais crónicos (DRC) em hemodiálise e terapêutica com EPOhr (32 respondedores e 31 ...

REJEIÇÃO HUMORAL AGUDA NO TRANSPLANTE RENAL: GRAVIDEZ COMO EVENTO SENSIBILIZANTE?

Potential cardiovascular risk protection of bilirubin in end-stage renal diseas...

We evaluated the potential cardiovascular risk protection of bilirubin in hemodialysis (HD) patients. An enlarged set of studies were evaluated in 191 HD patients, including hematological study, lipid profile, iron metabolism, nutritional, inflammatory markers, and dialysis adequacy. The TA duplication screening in the UDP-glucuronosyltransferase 1 A1 (UGT1A1) promoter region was also performed. The UGT1A1 geno...

Neutrophil and monocyte activation in chronic kidney disease patients under hem...

The aim of the present work was to further clarify leukocyte activation due to hemodialysis (HD) procedures and to investigate its relationship with recombinant human erythropoietin resistance. Therefore, we studied the expression of CXCR1 and CD11b on neutrophils, as well as the monocyte expression of CD11b, HLA-DR, and CD14. We studied 34 chronic kidney disease (CKD) patients under HD and recombinant human er...

Resistance to recombinant human erythropoietin therapy in haemodialysis patients

To better clarify the mechanism of resistance to recombinant human erythropoietin (rhEPO) therapy in haemodialysis patients, we studied systemic changes associated with this resistence in haemodialysis patients under rhEPO therapies, with particular interest on inflammation, leukocyte activation, ironstatus, oxidative stress and erythrocyte damage. We studied 63 chronic kidney disease (CKD) patients under haemo...

Hepcidin serum levels and resistance to recombinant human erythropoietin therap...

Neutrophil activation and resistance to recombinant human erythropoietin therap...

The aim of this work was to evaluate the neutrophil activation state in chronic kidney disease (CKD) patients under hemodialysis, and its linkage with resistance to recombinant human erythropoietin (rhEPO) therapy. Methods: We studied 63 CKD patients under hemodialysis and rhEPO treatment (32 responders and 31 non-responders to rhEPO therapy). In 20 of the CKD patients (10 responders and 10 non-responders to rh...

Band 3 profile as a marker of erythrocyte changes in chronic kidney disease pat...

Our aim was to study changes in red blood cell (RBC) membrane band 3 profile, as a cumulative marker of RBC changes, in chronic kidney disease (CKD) patients under haemodialysis and recombinant human erythropoietin (rhEPO) therapy and its linkage with resistance to this therapy. We studied 63 CKD patients, 32 responders and 31 non-responders to rhEPO therapy, and 26 healthy individuals. We evaluated the band 3 ...